**Chapter 9**

*Legume Crops - Prospects, Production and Uses*

cancer and various chronic conditions. Journal of Carcinogenesis. 2006;**5**:1-8.

[78] Koller WC, Rueda MG. Mechanism of action of dopaminergic agents in Parkinson's disease. Neurology. 1998;**50**. DOI: 10.1212/wnl.50.6\_suppl\_6.s11

DOI: 10.1186/1477-3163-5-14

[72] Fung SY, Tan NH, Liew SH, Sim SM, Aguiyi JC. The protective effects of *Mucuna pruriens* seed extract against histopathological changes induced by Malayan cobra (*Naja sputatrix*) venom in rats. Tropical Biomedicine.

[73] DeMaagd G, Philip A. Parkinson's disease and its management. Part 1: Disease entity, risk factors,

pathophysiology, clinical presentation, and diagnosis. Pharmacology & Therapeutics. 1994;**40**:504-510. DOI:

10.1136/bmj.308.6923.281

10.1136/jnnp.2003.028761

[75] Lieu CA, Venkiteswaran K, Gilmour TP, Rao AN, Petticoffer AC, Gilbert EV, et al. The antiparkinsonian and antidyskinetic mechanisms of *Mucuna pruriens* in the MPTP-treated nonhuman primate. Evidence-Based Complementary and Alternative Medicine. 2012;**2012**. DOI: 10.1155/2012/840247

[76] Kasote DM, Katyare SS, Hegde MV, Bae H. Significance of antioxidant potential of plants and its relevance to therapeutic applications. International

[77] Waris G, Ahsan H. Reactive oxygen species: Role in the development of

Journal of Biological Sciences. 2015;**11**:982-991. DOI: 10.7150/

[74] Katzenshlager R, Evans A, Manson A, Palsalos PN, Ratnaraj N, Watt H, et al. *Mucuna pruriens* in Parkinson's disease: A double blind clinical and pharmacological study. Journal of neurology, neurosurgery, and psychiatry. 2004;**75**:1672-1677. DOI:

[71] Shekins O. Anti-venom activity of *Mucuna pruriens* leaves extract against cobra snake (*Naja hannah*) venom. International Journal of Biochemistry Research & Review. 2014;**4**:470-480. DOI: 10.9734/

ijbcrr/2014/10394

2009;**26**:80-84

**146**

ijbs.12096
